The global immunodiagnostics market is in the moderate growth stage. The integration of mature clinical chemistry analyzers and restricted specificity and sensitivity of immunoassays have generated demand for integrated immunochemistry analyzers.The increasing volume of tests conducted due to rise in laboratory consolidation has driven the trend of automated analyzers globally.The Americas and Western European countries such as the UK, Germany, and France are major contributors to the market in terms of revenue generation. This is due to high level of automation in laboratories for high accuracy and efficiency.

PART 01: Executive summary 6

PART 02: Scope of the report 17

Market overview 17

Top-vendor offerings 19

PART 03: Market research methodology 20

Research methodology 20

Economic indicators 20

PART 04: Introduction 21

Key market highlights 21

PART 05: Market landscape 22

Market overview 22

Market size and forecast 24

Five forces analysis 26

PART 06: Market segmentation by product 27

Immunoassays 28

Immunodiagnostic instruments 30

PART 07: Market segmentation by application 32

Global oncology and endocrinology market 33

Global hepatitis and retrovirus testing market 35

Global infectious disease testing market 36

Global GI stool testing market 37

Others market 37

PART 08: Market segmentation by end-users 39

Hospitals and diagnostic laboratories 40

POLs 44

PART 09: Geographical segmentation 45

Immunodiagnostics market in Americas 47

Immunodiagnostics market in EMEA 48

Immunodiagnostics market in APAC 49

PART 10: Market drivers 50

Technological advances 50

Increasing adoption of POCT 51

Product development 52

PART 11: Impact of drivers 53

PART 12: Market challenges 54

Limited capability and high complexity of the

procedure 54

Lack of skilled technicians 54

Uneven reimbursement scenario 54

Growing concern over standardization and quality of

immunoassay kits 55

PART 13: Impact of drivers and challenges 56

PART 14: Market trends 57

Automation and system integration 57

Increased demand for biomarker-based tests 57

Growing use of multiplex bead-based immunoassays 58

PART 15: Vendor landscape 59

Competitive scenario 59

Key news 60

PART 16: Key vendor analysis 62

Abbott Laboratories 62

Danaher 65

Roche Diagnostics 67

Siemens Healthineers 70

Other prominent vendors 72

PART 17: Appendix 76

List of abbreviations 76

PART 18: Explore Technavio 77